Best Practice and Research. Clinical Haematology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

How old is too old for a transplant?
Publication date: Available online 12 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Daniel Weisdorf (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 13, 2021 Category: Hematology Source Type: research

Have Any Strategies in Ph-like ALL Been Shown to Be Effective?
Publication date: Available online 11 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Ibrahim Aldoss, Anjali S. Advani (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 12, 2021 Category: Hematology Source Type: research

Why isn’t there a One-Size-Fits-All Approach for Relapsed/Refractory Acute Myeloid Leukemia? Insights into Different Variables for Decision-Making
Publication date: Available online 11 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Ehab L. Atallah (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 12, 2021 Category: Hematology Source Type: research

Hypomethylating agents as maintenance therapy following allogeneic hematopoietic cell transplantation for myeloid malignancies
Publication date: Available online 11 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Frederick R. Appelbaum (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 12, 2021 Category: Hematology Source Type: research

Management of patients with higher-risk myelodysplastic syndromes after failure of hypomethylating agents: What is on the horizon?
Publication date: Available online 12 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Jan Philipp Bewersdorf, Amer M. Zeidan (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 12, 2021 Category: Hematology Source Type: research

Editorial Board / Aims & Scope
Publication date: December 2020Source: Best Practice & Research Clinical Haematology, Volume 33, Issue 4Author(s): (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - December 3, 2020 Category: Hematology Source Type: research

Index
Publication date: December 2020Source: Best Practice & Research Clinical Haematology, Volume 33, Issue 4Author(s): (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - December 3, 2020 Category: Hematology Source Type: research

Monoclonal antibodies in frontline acute lymphoblastic leukemia
Publication date: Available online 18 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Serena Chew, Nadya Jammal, Hagop Kantarjian, Elias Jabbour (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 19, 2020 Category: Hematology Source Type: research

Antibody based therapy in relapsed acute lymphoblastic leukemia
Publication date: Available online 18 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Nadya Jammal, Serena Chew, Elias Jabbour, Hagop Kantarjian (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 18, 2020 Category: Hematology Source Type: research

CD33 directed bispecific antibodies in acute myeloid leukemia
Publication date: Available online 18 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Mary C. Clark, Anthony Stein (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 18, 2020 Category: Hematology Source Type: research

Antibody-based targeted therapies
Publication date: Available online 5 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Farhad Ravandi (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 11, 2020 Category: Hematology Source Type: research

The promise of macrophage directed checkpoint inhibitors in myeloid malignancies
Publication date: Available online 6 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): David M. Swoboda, David A. Sallman (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 8, 2020 Category: Hematology Source Type: research

CD123 bi-specific antibodies in development in AML: What do we know so far?
Publication date: Available online 6 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Michael J. Slade, Geoffrey Uy (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 8, 2020 Category: Hematology Source Type: research

Antibody Targeted Therapies
Publication date: Available online 5 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Farhad Ravandi (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 6, 2020 Category: Hematology Source Type: research

Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?
Publication date: Available online 6 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Jan Philipp Bewersdorf, Amer M. Zeidan (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - November 6, 2020 Category: Hematology Source Type: research